JP2014506319A5 - - Google Patents

Download PDF

Info

Publication number
JP2014506319A5
JP2014506319A5 JP2013542211A JP2013542211A JP2014506319A5 JP 2014506319 A5 JP2014506319 A5 JP 2014506319A5 JP 2013542211 A JP2013542211 A JP 2013542211A JP 2013542211 A JP2013542211 A JP 2013542211A JP 2014506319 A5 JP2014506319 A5 JP 2014506319A5
Authority
JP
Japan
Prior art keywords
blood
variegin
seq
designated
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542211A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014506319A (ja
JP5937612B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/063086 external-priority patent/WO2012075407A2/en
Publication of JP2014506319A publication Critical patent/JP2014506319A/ja
Publication of JP2014506319A5 publication Critical patent/JP2014506319A5/ja
Application granted granted Critical
Publication of JP5937612B2 publication Critical patent/JP5937612B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542211A 2010-12-02 2011-12-02 血液安定剤を含む採血用デバイス Active JP5937612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41906310P 2010-12-02 2010-12-02
US61/419,063 2010-12-02
PCT/US2011/063086 WO2012075407A2 (en) 2010-12-02 2011-12-02 Blood collection devices containing blood stabilization agent

Publications (3)

Publication Number Publication Date
JP2014506319A JP2014506319A (ja) 2014-03-13
JP2014506319A5 true JP2014506319A5 (enExample) 2015-01-08
JP5937612B2 JP5937612B2 (ja) 2016-06-22

Family

ID=46172595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542211A Active JP5937612B2 (ja) 2010-12-02 2011-12-02 血液安定剤を含む採血用デバイス

Country Status (10)

Country Link
US (1) US10299714B2 (enExample)
EP (1) EP2645932B1 (enExample)
JP (1) JP5937612B2 (enExample)
CN (1) CN103384496B (enExample)
AU (1) AU2011336345B2 (enExample)
BR (1) BR112013013414B1 (enExample)
CA (1) CA2818522C (enExample)
ES (1) ES2572502T3 (enExample)
MX (1) MX346717B (enExample)
WO (1) WO2012075407A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2598660B1 (en) 2010-07-26 2017-03-15 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
EP4234583A3 (en) 2013-01-20 2024-01-24 Takeda Pharmaceutical Company Limited Evaluation and treatment of bradykinin-mediated disorders
RU2015136025A (ru) * 2013-02-01 2017-03-06 Бектон, Дикинсон энд Кампани Устройства для сбора крови, содержащие добавки, ингибирующие контактный путь свертывания крови
CA2927695C (en) 2013-10-21 2022-03-01 Dyax Corp. Diagnosis and treatment of autoimmune diseases
WO2015061183A1 (en) 2013-10-21 2015-04-30 Dyax Corp. Assays for determining plasma kallikrein system biomarkers
ES2786373T3 (es) * 2014-06-10 2020-10-09 Biomatrica Inc Estabilización de trombocitos a temperaturas ambiente
CN104068867A (zh) * 2014-06-27 2014-10-01 安徽信灵检验医学科技有限公司 一种真空采血系统及其使用方法
EP3099235B8 (en) 2014-07-02 2017-11-29 Site Saver, Inc. Venous access device
CN104634628B (zh) * 2014-12-16 2017-03-29 广东腾飞基因科技有限公司 一种血液稳定剂及其应用
WO2016153590A2 (en) 2015-01-22 2016-09-29 The Regents Of The University Of California Platelet rich plasma and bone marrow aspirate cell separation and removal methods and devices
EP4354146B1 (en) * 2015-10-19 2026-04-15 Takeda Pharmaceutical Company Limited Immunoassay for the detection of cleaved high molecular weight kininogen
CN108697491B (zh) * 2015-11-03 2023-06-06 加利利医疗中心保健公司 用血液处理人造骨植入物的装置和方法
KR20250047404A (ko) 2015-12-08 2025-04-03 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
CN108342381A (zh) * 2017-01-24 2018-07-31 梁建国 一种用于稳定保存外周血中循环游离dna的溶剂
CN106913348B (zh) * 2017-03-31 2023-06-23 汪学耀 一种预稀释真空采血管及测量血小板数目的方法
CN107201307B (zh) * 2017-05-27 2019-09-13 广州基赛生物科技有限公司 一种采血管及其应用
CN107727587B (zh) * 2017-09-22 2020-06-19 宁波瑞源生物科技有限公司 一种抗凝血酶ⅲ测定试剂盒及其检测方法
CN107569244A (zh) * 2017-10-16 2018-01-12 李玉斌 一种血管外科用采血管
DK3710806T3 (en) * 2017-11-15 2024-09-23 Radiometer Medical Aps Heparin-based blood sampler without platelet activation
US12426815B2 (en) * 2018-04-27 2025-09-30 Arizona Board Of Regents On Behalf Of The University Of Arizona Integrated device for self-collecting and automated pre-processing of biological fluids
DE102018218739B3 (de) * 2018-11-01 2020-03-19 Sarstedt Ag & Co. Kg Blutentnahmeröhre und Verfahren zur Präparation
US12357208B2 (en) * 2019-10-16 2025-07-15 Becton, Dickinson And Company Multi-chamber blood collection device and related systems and methods
EP4267003A1 (en) * 2020-12-22 2023-11-01 Radiometer Medical ApS Blood sampler containing anti-platelet agent and water-soluble matrix material

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB711779A (en) * 1950-07-07 1954-07-14 Nat Res Dev Improvements in or relating to electronic information storage systems and discharge tubes therefor
JPS6053845A (ja) * 1983-09-05 1985-03-27 Terumo Corp 血液分離管
NZ236033A (en) * 1989-11-13 1994-11-25 Davol Inc Blood pump: filtering with tangential flow separation
WO1993003748A1 (en) 1991-08-13 1993-03-04 Temple University - Of The Commonwealth System Of Higher Education Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
JPH06192291A (ja) * 1992-09-07 1994-07-12 Nippon Steel Corp 新規ペプチドとそれを用いた血小板凝集抑制剤及び血液凝固抑制剤
JP2723473B2 (ja) * 1994-09-22 1998-03-09 ブーク メデイテツク エイ/エス 硫酸化糖類の用途
CA2221865C (en) 1995-06-09 2007-12-11 The Regents Of The University Of Michigan Bradykinin analogs as selective thrombin inhibitors
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
CA2288027A1 (en) 1997-04-23 1998-10-29 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6544750B1 (en) 1999-08-17 2003-04-08 Thromgen, Inc. Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
UA75093C2 (en) * 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
AUPR612801A0 (en) * 2001-07-04 2001-07-26 Australian National University, The Linked cyclitols and their polysulfated derivatives
WO2003095974A2 (en) 2002-05-07 2003-11-20 Becton, Dickinson And Company Collection assembly
JP4496407B2 (ja) * 2002-05-13 2010-07-07 ベクトン・ディキンソン・アンド・カンパニー プロテアーゼ阻害剤試料採取システム
CA2445204C (en) 2002-10-16 2014-08-12 Streck Laboratories, Inc. Method and device for collecting and preserving cells for analysis
US7074765B2 (en) 2003-05-01 2006-07-11 The Regents Of The University Of Michigan Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
US20090123907A1 (en) * 2004-07-22 2009-05-14 Shanbrom Technologies, Llc Lysine citrate for plasma protein and donor protection
JP2006288680A (ja) * 2005-04-11 2006-10-26 Enomoto Co Ltd 採血キット
US7879792B2 (en) 2005-06-02 2011-02-01 The Regents Of The University Of Michigan Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
JP2008185564A (ja) * 2007-01-31 2008-08-14 Fujimori Kogyo Co Ltd 血液凝固能の検査方法および血液凝固能の検査装置
GB0711779D0 (en) 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
WO2009017689A2 (en) * 2007-08-02 2009-02-05 Government Of The U. S. A., As Represented By The Secretary, Dept. Of Health And Human Services Methods for detection and prevention of tick infestation and pathogen transmission
KR101718375B1 (ko) * 2007-12-04 2017-03-22 프로테오바이오엑티브스 피티와이 엘티디 전구 세포의 보호 및 그의 분화 조절
GB0907698D0 (en) * 2009-05-05 2009-06-10 Univ Singapore Method of modifying serine protease inhibitors

Similar Documents

Publication Publication Date Title
JP2014506319A5 (enExample)
CN103384496B (zh) 含有血液稳定剂的血液收集装置
Baaten et al. Platelet abnormalities in CKD and their implications for antiplatelet therapy
Daniels et al. Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results
JP2022190137A (ja) 周囲温度における血小板の安定化
Tucker et al. Clot retraction
Yamamoto et al. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential
JP2016505159A5 (enExample)
Parker et al. The role of platelet P2Y12 receptors in inflammation
WO2015039126A1 (en) Compositions and methods for treatment of hsct-associated thrombotic microangiopathy
US20090012136A1 (en) Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists
RU2015136025A (ru) Устройства для сбора крови, содержащие добавки, ингибирующие контактный путь свертывания крови
DE602005016465D1 (de) Verfahren zum testen der wirksamkeit eines antithrombosemittels
Jing et al. Neutrophil extracellular traps (NETs): the role of inflammation and coagulation in COVID-19
US8741873B2 (en) Controls and kit for thrombocyte activity tests
RU2016151668A (ru) Определение состояний в центрифугированной крови по измеренному давлению
JP2012220493A5 (enExample)
KR20180097611A (ko) 적혈구 침강 속도의 감소
Sternberg et al. Platelet activation in the postoperative period after lung transplantation
ES2706995T3 (es) Procedimiento para medir la generación de trombina
Morishima et al. Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats
Khafagy et al. Perioperative effects of anesthesia and surgery on inflammation-coagulation interaction
Sari et al. Various growth factor yields in various platelet rich plasma processing methods
Drabik et al. Unsolved issues of the efficacy and safety of edoxaban
Kitashoji et al. Development of non-antithrombin-mediated heparin resistance models using platelet factor 4 and the effect of antithrombin in these models